Merz Aesthetics
Karl Kokrhoun serves as the Chief Financial Officer at Merz Aesthetics, bringing extensive experience from various leadership roles in finance within the pharmaceutical industry. Prior positions include Head Finance BTD at Novartis Pharma AG, Head Finance NBS Germany & Europe at Sandoz International AG, and Head Finance Transitional Service Agreement at Novartis Consumer Health GmbH. Additionally, Karl held the role of Head Finance NBS, HR, Procurement, FRAOps, Legal & Communication a.i. at Novartis International AG and managed the Finance Transformation Program. Educational background includes a degree from Hochschule München University of Applied Sciences from 1998 to 2002.
Merz Aesthetics
6 followers
Merz Aesthetics is a medical aesthetics business with a long history of empowering health care professionals, patients and employees to live every day with confidence. We aim to help people around the world look, feel and live like the best versions of themselves — however they define it. Clinically proven, its product portfolio includes injectables, devices and skin care treatments designed to meet each patient’s needs with high standards of safety and efficacy. Being family owned for more than 115 years, Merz Aesthetics is known for building unique connections with customers who feel like family. Merz Aesthetics’ global headquarters is in Raleigh, N.C., USA, with a commercial presence in 90 countries worldwide. It is also a part of Merz Group, which was founded in 1908 and is based in Frankfurt, Germany. Learn more at merzaesthetics.com.